Upstream Bio is based in Waltham, MA. It has raised $200M in total funding. Latest round: Series A. Backed by OrbiMed, Maruho Co., Ltd., Access Biotechnology.
Upstream Bio is based in Waltham, MA. Upstream Bio has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for Upstream Bio runs through 2022; nothing later has been disclosed. Investors on record include OrbiMed, Maruho Co., Ltd., Access Biotechnology, Decheng Capital, HBM Healthcare Investments, TCG X and 3 others. 9 distinct backers are named across the disclosed rounds.
Upstream Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Waltham below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026